AJ Lanigan: Indeed. In Reality, pharma providers are building massive money with solutions like Keytruda and Opdivo that deal with PD-one and PD-L1. Right here’s the super awesome section: visualize checkpoints as traffic signals. You don’t want an immune process that’s running wild like a freight prepare above a cliff. waiting for link from Social Bookmarking (2)